EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy and safety of add-on dextromethorphan on irritability in children with ADHD treated with methylphenidate: A randomized double-blind controlled trial

Pei-Yin Pan, Chin-Bin Yeh

Journal of Affective Disorders · 2025

DOI: 10.1016/j.jad.2025.119546 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Pei-Yin Pan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Hauptthemen laut MEDLINE: Dextromethorphan, Methylphenidate, Attention Deficit Disorder with Hyperactivity, Irritable Mood. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Science and Technology Council, Tri-Service General Hospital, National Defense Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Converging evidence suggests that childhood irritability is prospectively associated with major depressive disorder. Dextromethorphan has shown efficacious in improving depressive symptomatology in adults. This trial aimed to investigate the efficacy and safety of add-on dextromethorphan on irritability in children with attention-deficit/hyperactivity disorder (ADHD) receiving methylphenidate treatment. METHODS: This randomized, double-blind, parallel-group trial evaluated dextromethorphan/methylphenidate versus placebo/methylphenidate in patients 7-17 years old with ADHD and comorbid irritability, which defined by the score of the Affective Reactivity Index (ARI) parent-report form ≥6. Patients were randomly assigned to receive optimal dose of methylphenidate and either dextromethorphan or placebo, 30 mg once daily for the first 2 weeks and 60 mg once daily thereafter, for a total of 8 weeks. The primary outcome was the change from baseline to week 8 in the ARI score. RESULTS: A total of 19 patients were randomized (dextromethorphan, N = 8; placebo, N = 11), and Dextromethorphan was significantly superior to the placebo in reducing the ARI score at Week 2 (-5.82 points vs. -0.32 points; least-squares mean difference - 5.50; 95 % CI -8.13, -2.87), Week 4 (-6.49 points vs. -1.96 points; least-squares mean difference - 4.53; 95 % CI -7.13, -1.94), and Week 8 (-4.98 points vs. -2.21 points; least-squares mean difference - 2.77; 95 % CI -5.29, -0.24). The effects of treatment by time interaction were significant at week 2, week 4, and week 8 (p < 0.001, p < 0.001, and p = 0.015, respectively). CONCLUSIONS: Adjunctive dextromethorphan might be efficacious in the treatment of irritability in children with ADHD treated with methylphenidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DextromethorphanMethylphenidateAttention Deficit Disorder with HyperactivityIrritable MoodCentral Nervous System StimulantsHumansChildDouble-Blind MethodMaleFemaleAdolescentDrug Therapy, CombinationTreatment Outcome

Stichwörter der Autor:innen

Attention-deficit/hyperactivity disorderDextromethorphanDouble-blind studyEmotion dysregulationIrritabilityMethylphenidate

Substanzen

DextromethorphanMethylphenidateCentral Nervous System Stimulants

Autor:innen und Institutionen

  • Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Electronic address: chinbinyeh@gmail.com.

Förderung

  • National Science and Technology Council
  • Tri-Service General Hospital
  • National Defense Medical Center

Zitieren

APA

Pan, P. Y., & Yeh, C. B. (2025). Efficacy and safety of add-on dextromethorphan on irritability in children with ADHD treated with methylphenidate: A randomized double-blind controlled trial. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.119546

Vancouver

Pan PY, Yeh CB. Efficacy and safety of add-on dextromethorphan on irritability in children with ADHD treated with methylphenidate: A randomized double-blind controlled trial. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.119546

BibTeX
@article{Pan2025,
  author = {Pan, Pei-Yin and Yeh, Chin-Bin},
  title = {Efficacy and safety of add-on dextromethorphan on irritability in children with ADHD treated with methylphenidate: A randomized double-blind controlled trial},
  journal = {Journal of Affective Disorders},
  year = {2025},
  doi = {10.1016/j.jad.2025.119546}
}
Kostenlos starten →